Get informed when a big investor buys or sells
+ FollowOvervalued by 13.2% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $771,520.00 |
|---|---|
| Enterprise Value | $576,622.00 |
| Earnings per Share | $-0.21 |
| Beta | 2.29 |
| Outstanding Shares | 8,011,630 |
| P/E Ratio | -0.55 |
|---|---|
| PEG | -0.23 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 5.36 |
| Enterprise Value to EBIT | -0.36 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercializ...